Our division is internationally recognized for research in asthma, stem cells, obesity, and lung diseases. Faculty conduct clinical studies on asthma, pulmonary fibrosis, critical care, and cystic fibrosis, emphasizing airway biology and obesity in both basic and translational research.
Pulmonary Vascular Disease Program
Our PH specialists work with a multidisciplinary team including cardiology and rheumatology, to expertly evaluate and treat those with PH. We also evaluate and treat patients with pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
More about the Pulmonary Vascular Disease Program
Cystic Fibrosis Clinical Research
Our center is a site in the Cystic Fibrosis Therapeutics Development Network (CF TDN), a large national network of clinical-trial sites. As such, our goal is to work collaboratively with the TDN and Study Sponsors to complete pivotal trials in cystic fibrosis therapeutics.
Cystic Fibrosis Clinical TrialsAdditional Research Areas
- Mathematical modeling of lung mechanics
- Occupational and environmental lung diseases
- Pulmonary physiology and lung mechanics in asthma
- Pathogenesis of acute lung injury
- Airway epithelial signaling in inflammation
- Redox signaling and inflammatory lung disease
- Signaling pathways and gene regulation of cytokines
- Oxidative stress in lung inflammation
- Repopulation of pulmonary epithelium with stem cell transplantation
- Gene and stem cell therapies for lung disease
- Impact of system changes and organization on medical outcomes in the ICU
- Communication with critically and seriously ill patients and their families
- Clinical trials in critically ill patients (e.g. exercise, nutrition, and novel interventions) to improve outcomes